uniQure N.V. (QURE) Reaches $23.26 After 4.00% Down Move; Ameriprise Financial (AMP) Has 1.13 Sentiment

March 14, 2018 - By Hazel Jackson

The stock of uniQure N.V. (NASDAQ:QURE) is a huge mover today! The stock decreased 7.37% or $1.85 during the last trading session, reaching $23.26. About 301,296 shares traded. uniQure N.V. (NASDAQ:QURE) has declined 52.65% since March 14, 2017 and is downtrending. It has underperformed by 69.35% the S&P500.The move comes after 9 months negative chart setup for the $714.58 million company. It was reported on Mar, 14 by Barchart.com. We have $22.33 PT which if reached, will make NASDAQ:QURE worth $28.58 million less.

Ameriprise Financial, Inc., through its subsidiaries, provides various financial services and products to individual and institutional clients in the United States and internationally. The company has market cap of $23.11 billion. The companyÂ’s Advice & Wealth Management segment provides financial planning and advice, as well as full-service brokerage services primarily to retail clients through its advisors. It has a 16.73 P/E ratio. The Company’s Asset Management segment offers investment management and advice, and investment products to retail, high net worth, and institutional clients through unaffiliated third party financial institutions and institutional sales force.

uniQure N.V., a biopharmaceutical company, engages in the discovery, development, and commercialization of gene therapies in the Netherlands. The company has market cap of $714.58 million. The companyÂ’s principle programs include AMT-060, a gene therapy that has completed Phase I/II clinical trial for the treatment of hemophilia B; S100A1, a preclinical product candidate for the treatment of congestive heart failure; and AMT-130 for the treatment of huntington's disease. It currently has negative earnings. It also provides Glybera, a gene therapy product that has approved for the treatment of patients with lipoprotein lipase deficiency.

Analysts await uniQure N.V. (NASDAQ:QURE) to report earnings on March, 21. They expect $-0.68 EPS, down 161.54% or $0.42 from last year’s $-0.26 per share. After $-0.40 actual EPS reported by uniQure N.V. for the previous quarter, Wall Street now forecasts 70.00% negative EPS growth.

Among 13 analysts covering uniQure N.V. (NASDAQ:QURE), 10 have Buy rating, 0 Sell and 3 Hold. Therefore 77% are positive. uniQure N.V. had 28 analyst reports since August 7, 2015 according to SRatingsIntel. Janney Capital initiated the stock with “Buy” rating in Tuesday, December 1 report. The stock of uniQure N.V. (NASDAQ:QURE) earned “Buy” rating by Zacks on Tuesday, September 1. Oppenheimer maintained uniQure N.V. (NASDAQ:QURE) rating on Monday, September 21. Oppenheimer has “Outperform” rating and $50 target. Jefferies downgraded uniQure N.V. (NASDAQ:QURE) rating on Tuesday, November 22. Jefferies has “Hold” rating and $8 target. As per Wednesday, January 3, the company rating was initiated by Janney Capital. Oppenheimer maintained it with “Buy” rating and $1700 target in Wednesday, June 28 report. The company was maintained on Thursday, October 1 by Chardan Capital Markets. The company was reinitiated on Monday, November 30 by TH Capital. The firm has “Buy” rating by WallachBeth Capital given on Friday, August 28. Roth Capital maintained the shares of QURE in report on Monday, September 21 with “Buy” rating.

Northrock Partners Llc holds 4.53% of its portfolio in Ameriprise Financial, Inc. for 79,819 shares. Lyrical Asset Management Lp owns 2.06 million shares or 4% of their US portfolio. Moreover, Boyar Asset Management Inc. has 3.66% invested in the company for 32,968 shares. The Missouri-based Atwood & Palmer Inc has invested 3.1% in the stock. Aristotle Capital Management Llc, a California-based fund reported 2.46 million shares.

Ratings analysis reveals 25% of Ameriprise Financial’s analysts are positive. Out of 4 Wall Street analysts rating Ameriprise Financial, 1 give it “Buy”, 0 “Sell” rating, while 3 recommend “Hold”. The lowest target is $112.0 while the high is $120.0. The stock’s average target of $116 is -26.55% below today’s ($157.93) share price. AMP was included in 4 notes of analysts from October 7, 2016. The stock of Ameriprise Financial, Inc. (NYSE:AMP) has “Buy” rating given on Thursday, January 26 by Citigroup. The rating was downgraded by SunTrust to “Hold” on Monday, December 19. The rating was initiated by Credit Suisse with “Neutral” on Friday, October 7. Deutsche Bank downgraded it to “Hold” rating and $112.0 target in Friday, October 14 report.

The stock decreased 0.62% or $0.98 during the last trading session, reaching $157.93. About 174,925 shares traded. Ameriprise Financial, Inc. (AMP) has risen 30.25% since March 14, 2017 and is uptrending. It has outperformed by 13.55% the S&P500.

Since January 1, 0001, it had 0 buys, and 10 selling transactions for $11.64 million activity.

Analysts await Ameriprise Financial, Inc. (NYSE:AMP) to report earnings on April, 23. They expect $3.52 earnings per share, up 30.37% or $0.82 from last year’s $2.7 per share. AMP’s profit will be $515.08M for 11.22 P/E if the $3.52 EPS becomes a reality. After $3.26 actual earnings per share reported by Ameriprise Financial, Inc. for the previous quarter, Wall Street now forecasts 7.98% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News